Skip to content
10-Q

Quarterly Report

Oragenics, Inc. OGEN

0001641172-25-009464

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 21.48M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $3.42M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $864.84K
Total Liabilities Q1 2025 · Mar 31, 2025 $3.73M
Total Liabilities Q1 2025 · Dec 31, 2024 $1.68M
Current Assets Q1 2025 · Mar 31, 2025 $3.87M
Current Assets Q1 2025 · Dec 31, 2024 $1.47M
Total Assets Q1 2025 · Mar 31, 2025 $3.87M
Total Assets Q1 2025 · Dec 31, 2024 $1.47M
Shares Diluted Q1 2025 · Mar 31, 2024 3.5M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$3.06M
Stockholders Equity Q1 2025 · Mar 31, 2024 $2.63M
Stockholders Equity Q1 2025 · Dec 31, 2023 $3.17M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.70
Eps Basic Q1 2025 · Mar 31, 2024 −$0.70
Rd Expense Q1 2025 · Mar 31, 2024 $663.41K
Net Income Q1 2025 · Mar 31, 2024 −$2.45M
Operating Income Q1 2025 · Mar 31, 2024 −$2.46M